Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+756K
-
Total reported value, excl. options
-
$474M
-
Value change
-
+$22.3M
-
Number of buys
-
40
-
Number of sells
-
-27
-
Price
-
$26.34
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2015
85 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2015.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 62.5M outstanding shares and own 28.79% of the company stock.
Largest 10 shareholders include FMR LLC (3.52M shares), BVF INC/IL (2.28M shares), Visium Asset Management, LP (1.02M shares), Partner Fund Management, L.P. (1.01M shares), RA CAPITAL MANAGEMENT, LLC (878K shares), FIL Ltd (804K shares), LORD, ABBETT & CO. LLC (752K shares), RS INVESTMENT MANAGEMENT CO LLC (740K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (680K shares), and BlackRock Fund Advisors (571K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.